122
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Treatments for borderline personality disorder: integrating evidence into practice

Pages 42-51 | Published online: 11 Jul 2009

  • AMERICAN PSYCHIATRIC ASSOCIATION (1980). Diagnostic and statistical manual of mental disorders (3rd edition). Washington, DC: American Psychiatric Association.
  • AMERICAN PSYCHIATRIC ASSOCIATION (1994). Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC: American Psychiatric Association.
  • AMERICAN PSYCHIATRIC ASSOCIATION (2001). Practice guidelines for the treatments ppf patients with borderline personality disorder. American Journal of Psychiatry, 158(10)(Suppl.).
  • ARNTZ, A. (1999). Do personality disorders exist? On the validity of the concept and its cognitive behavioural formulation and treatment. Behaviour Research and Therapy, 37, S97-S134.
  • BATEMAN, A.W. & FONAGY, P. (1999). Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry, 156(10), 1563-1569.
  • BATEMAN, A.W. & FONAGY, P. (2000). Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138-143.
  • BATEMAN, A.W. & FONAGY, P. (2001). Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. American Journal of Psychiatry, 158(1), 36-42.
  • BECK, A.T. & FREEMAN, A. (1990). Cognitive therapy of personality disorders. New York: Guilford Press.
  • BECKER,D.F.,GRILO, C.M.,EDELL,W.S.& MCGLASHAN, T.H. (2000). Comorbidity of borderline personality disorder with other personality disorders in hospitalized adolescents and adults. American Journal of Psychiatry, 157(12), 2011-2016.
  • BENDER, D.S., DOLAN, R.T., SKODOL, A.E., SANISLOW, C.A., DYCK, I.R., MCGLASHAN, T.H., SHEA, M.T., ZANARINI, M.C., OLDHAM, J.M. & GUNDERSON, J.G. (2001). Treatment utilization by patients with personality disorders. American Journal of Psychiatry, 158(2), 295-302.
  • BOHUS, M., HAAF, B., STIGLMAYR, C., POHL, U., BOHME, R. & LINEHAN, M. (2000). Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder--a prospective study. Behaviour Research and Therapy, 38(9), 875-887.
  • CHIESA, M. & FONAGY, P. (2000). Cassel personality disorder study. Methodology and treatment effects. British Journal of Psychiatry, 176, 485-491.
  • COCCARO, E.F. & KAVOUSSI, R.J. (1997). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry, 54(12), 1081-1088.
  • COWDRY, R.W. & GARDNER, D.L. (1988). Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Archives of General Psychiatry, 45(2), 111-119.
  • DE LA FUENTE, J.M. & LOTSTRA, F. (1994). A trial of car-bamazepine in borderline personality disorder. European Neuropsychopharmacology , 4(4), 479-486.
  • DOLAN, B., WARREN, F. & NORTON, K. (1997). Change in borderline symptoms one year after therapeutic community treatment for severe personality disorder. British Journal of Psychiatry, 171, 274-279.
  • EVANS, K., TYRER, P., CATALAN, J., SCHMIDT, U., DAVIDSON, K., DENT, J., TATA, P., THORNTON, S., BARBER, J. & THOMPSON, S. (1999). Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychological Medicine, 29(1), 19-25.
  • FRANKENBURG, F.R. & ZANARINI, M.C. (1993). Clozapine treatment of borderline patients: a preliminary study. Comprehensive Psychiatry, 34(6), 402-405.
  • GOLDBERG, S.C., SCHULZ, S.C., SCHULZ, P.M., RESNICK, R.J., HAMER, R.M. & FRIEDEL, R.O. (1986). Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Archives of General Psychiatry, 43(7), 680-686.
  • GRILO, C.M., LEVY, K.N., BECKER, D.F., EDELL, W.S. & MCGLASHAN, T.H. (1996). Comorbidity of DSM-III-R axis I and II disorders among female inpatients with eating disorders. Psychiatric Services, 47(4), 426-429.
  • GRILO, C.M., MARTINO, S., WALKER, M.L., BECKER, D.F., EDELL, W.S. & MCGLASHAN, T.H. (1997). Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substanceuse disorders. American Journal of Psychiatry, 154(9), 1305-1307.
  • GRINKER, R., WERBLE, B. & BRYE, R. (1968). The borderline syndrome, a behavioural study of ego functions. New York: Basic Books.
  • GUNDERSON, J.G. (1984) Borderline personality disorder. Washington, DC: American Psychiatric Press.
  • GUNDERSON, J.G. (2001). Borderline personality disorder: a clinical guide. Washington, DC: American Psychiatric Press.
  • GUNDERSON, J.G. & PHILLIPS, K.A. (1991). A current view of the interface between borderline personality disorder and depression. American Journal of Psychiatry, 148(8), 967-975.
  • GUNDERSON, J.G., KOLB, J.E. & AUSTIN, V. (1981). Diagnostic interview for borderline patients (DIB). American Journal of Psychiatry, 137(7), 896-903.
  • HAWKINS, K.A. & SINHA, R. (1998). Can line clinicians master the conceptual complexities of dialectical behavior therapy? An evaluation of a State Department of Mental Health training program. Journal of Psychiatric Research, 32(6), 379-384.
  • HAWTON, K., TOWNSEND, E., ARENSMAN, E., GUNNELL, D., HAZELL, P., HOUSE, A. & VAN HEERINGEN, K. (2000). Psychosocial versus pharmacological treatments for deliberate self harm. Cochrane Database Systematic Review, 2, CD001764.
  • HAWTON, K., ARENSMAN, E., TOWNSEND, E., BREMNER, S., FELDMAN, E., GOLDNEY, R., GUNNELL, D., HAZELL, P., VAN HEERINGEN, K., HOUSE, A., OWENS, D., SAKINOFSKY, I. & TRASKMAN-BENDZ, L. (1998). Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventingrepetition.BritishMedicalJournal, 15,317(7156): 441-447.
  • HOLLANDER, E., ALLEN, A., LOPEZ, R.P., BIENSTOCK, C.A., GROSSMAN, R., SIEVER, L.J., MERKATZ, L. & STEIN, D.J. (2001). A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry, 62(3), 199-203.
  • KERNBERG, O. (1967). Borderline personality organisation. Journal of American Psychoanalytic Association, 15, 641-685.
  • LINEHAN, M.M. (1993). Cognitive behavioral treatment of borderline personality disorder. New York: Guilford Press.
  • LINEHAN, M.M., HEARD, H.L. & ARMSTRONG, H.E. (1993). Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry, 50(12), 971-974.
  • LINEHAN, M.M., ARMSTRONG, H.E., SUAREZ, A., ALLMON, D. & HEARD, H.L. (1991). Cognitive behavioural therapy of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060-1064.
  • LINEHAN, M.M., SCHMIDT III, H., DIMEFF, L.A., CRAFT, J.C., KANTER, J. & COMTOIS, K.A. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal of Addiction, 8(4), 279-292.
  • LINKS, P. (1990). Lithium therapy for borderline patients. Journal of Personality Disorders, 4, 173-181.
  • LIVESLEY, W.J. (2000). A practical approach to the treatment of patients with borderline personality disorder. Psychiatric Clinics North America, 23(1), 211-232.
  • MARKOVITZ, P.J. (1995). Pharmacotherapy of impulsivity aggression and related disorders. In: E. HOLLANDER & D. STEIN (Eds), Impulsivity and aggression. Chichester: Wiley.
  • MARZIALI, E. & MUNROE-BLUM, H. (1994). Interpersonal group psychotherapy for borderline personality disorder. New York: Basic Books.
  • MARZIALI, E., MUNROE-BLUM, H. & MCCLEARY, L. (1997). The contribution of group cohesion and group alliance to the outcome of group psychotherapy. International Journal of Group Psychotherapy, 47(4), 475-497.
  • MCGLASHAN, T.H. (1983). The borderline syndrome. I. Testing three diagnostic systems. Archives of General Psychiatry, 40(12), 1311-1318.
  • MCGLASHAN, T.H., GRILO, C.M., SKODOL, A.E., GUNDERSON, J.G., SHEA, M.T., MOREY, L.C., ZANARINI, M.C., STOUT, R.L. (2000). The collaborative longitudinal personality disorders study: baseline Axis I/ II and II/II diagnostic co-occurrence. Acta Psychiatrica Scandinavica, 102(4), 256-264.
  • MCMAIN, S., KORMAN, L.M. & DIMEFF, L. (2001). Dialectical behavior therapy and the treatment of emotion dysregulation. Journal of Clinical Psychology, 57(2), 183-196.
  • MEARES, R., STEVENSON, J. & COMERFORD, A. (1999). Psychotherapy with borderline patients: I. A comparison between treated and untreated cohorts. Australian and New Zealand Journal of Psychiatry, 33(4), 467-472 (discussion 478-481).
  • MILLER, C.R., EISNER, W. & ALLPORT, C. (1994). Creative coping: a cognitive-behavioral group for borderline personality disorder. Archives of Psychiatric Nursing, 8(4), 280-285.
  • MONTGOMERY, S.A. & MONTGOMERY, D. (1982). Pharmacological prevention of suicidal behaviour. Journal of Affective Disorders, 4(4), 291-298.
  • MONTGOMERY, S.A., ROY, D. & MONTGOMERY, D.B. (1983). The prevention of recurrent suicidal acts. British Journal of Clinical Pharmacology, 15(Suppl. 2), 183S-188S.
  • OQUENDO, M.A. & MANN, J.J. (2000). The biology of impulsivity and suicidality. Psychiatric Clinics North America, 23(1), 11-25.
  • PARSONS, B., QUITKIN, F.M., MCGRATH, P.J., STEWART, J.W., TRICAMO, E., OCEPEK-WELIKSON, K., HARRISON, W., RABKIN, J.G., WAGER, S.G. & NUNES, E. (1989). Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacology Bulletin, 25(4), 524-534.
  • PINTO, O.C. & AKISKAL, H.S. (1998). Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. Journal of Affective Disorders, 51(3), 333-343.
  • PERRY, J.C., BANON, E. & IANNI, F. (1999). Effectiveness of psychotherapy for personality disorders. American Journal of Psychiatry, 156, 1312-1321.
  • ROTH, A.S., OSTROFF, R.B. & HOFFMAN, R.E. (1996). Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial. Journal of Clinical Psychiatry, 57(6), 233-237.
  • RUSS, M.J., ROTH, S.D., KAKUMA, T., HARRISON, K. & HULL, J.W. (1994). Pain perception in self-injurious borderline patients: naloxone effects. Biological Psychiatry, 35(3), 207-209.
  • RYLE, A. (1997). The structure and development of borderline personality disorder: a proposed model. British Journal of Psychiatry, 170, 82-87.
  • RYLE, A. & GOLYNKINA, K. (2000). Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. British Journal of Medical Psychology, 73(Part 2), 197-210.
  • SALKOVSKIS, P.M., ATHA, C. & STORER, D. (1990). Cognitive behavioural problem solving in the treatment of patients who repeatedly attempt suicide; a controlled trial. British Journal of Psychiatry, 157, 871-876.
  • SALZMAN, C., WOLFSON, A.N., SCHATZBERG, A., LOOPER, J., HENKE, R., ALBANESE, M., SCHWARTZ, J. & MIYAWAKI, E. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15(1), 23-29.
  • SANISLOW, C.A., GRILO, C.M. & MCGLASHAN, T.H. (2000). Factor analysis of the DSM-III-R borderline personality disorder criteria in psychiatric inpatients. American Journal of Psychiatry, 57(10), 1629-1633.
  • SCHIMMEL, P. (1997). Swimming against the tide? A review of the therapeutic community. Australian and New Zealand Journal of Psychiatry, 31(1), 120-127.
  • SCHULZ, S.C., CAMLIN, K.L., BERRY, S.A. & JESBERGER, J.A. (1999). Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biological Psychiatry, 46(10), 1429-1435.
  • SHEARIN, E.N. & LINEHAN, M.M. (1994). Dialectical behavior therapy for borderline personality disorder: theoretical and empirical foundations. Acta Psychiatrica Scandinavica, 379(Suppl.), 61-68.
  • SKODOL, A.E., STOUT, R.L., MCGLASHAN, T.H., GRILO, C.M., GUNDERSON, J.G., SHEA, M.T., MOREY, L.C., ZANARINI, M.C., DYCK, I.R. & OLDHAM, J.M. (1999). Co-occurrence of mood and personality disorders: a report from the Collaborative Longitudinal Personality Disorders Study (CLPS). Depression and Anxiety, 10(4), 175-182.
  • SOLOFF, P.H., GEORGE, A., NATHAN, R.S. & SCHULZ, P.M. (1987). Characterizing depression in borderline patients. Journal of Clinical Psychiatry, 48(4), 155-157.
  • SOLOFF, P.H., LIS, J.A., KELLY, T., CORNELIUS, J. & ULRICH, R. (1994). Risk factors for suicidal behavior in borderline personality disorder. American Journal of Psychiatry, 151(9), 1316-1323.
  • SOLOFF, P.H., CORNELIUS, J., GEORGE, A., NATHAN, S., PEREL, J.M. & ULRICH, R.F. (1993). Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry, 50(5), 377-385.
  • SOLOFF, P.H., GEORGE, A., NATHAN, R.S., SCHULZ, P.M., ULRICH, R.F. & PEREL, J.M. (1986). Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry, 43(7), 691-697.
  • SOLOFF, P.H., GEORGE, A., NATHAN, S., SCHULZ, P.M., CORNELIUS, J.R., HERRING, J. & PEREL, J.M. (1989). Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Journal of Clinical Psychopharmacology, 9(4), 238-246.
  • SPRINGER, T. & SILK, K.R. (1996). A review of inpatient group therapy for borderline personality disorder. Harvard Review of Psychiatry, 3(5), 268-278.
  • STEVENSON, J. & MEARES, R. (1992). An outcome study ofpsychotherapyfor patients with borderline personality disorder. American Journal of Psychiatry, 149(3), 358-362.
  • STEVENSON, J. & MEARES, R. (1999). Psychotherapy with borderline patients: II. A preliminary cost benefit study. Australian and New Zealand Journal of Psychiatry, 33(4), 473-477 (discussion 478-481).
  • STONE, M.H. (1989). The course of borderline personality disorder. In: A. TASMAN, R.E. HALES & A.J. FRANCES (Eds), Review of Psychiatry (Vol. 8, pp. 103-123). Washington, DC: American Psychiatric Press.
  • SWARTZ, M., BLAZER, D., GEORGE, L. & WINFIELD, I. (1990). Estimating the prevalence of borderline personality disorder in the community. Journal of Personality Disorders, 4, 257-272.
  • WINSTON, A., LAIKIN, M., POLLACK, J., SAMSTAG, L.W., MCCULLOUGH, L., MURAN, J.C. (1994). Short-term psychotherapy of personality disorders. American Journal of Psychiatry, 151(2), 190-194.
  • YOUNG, J.E. (1999). Cognitive therapy for personality disorders: a schema-focused approach (3rd edition). Sarasota, FL: Professional Resource Press.
  • ZANARINI, M.C., FRANKENBURG, F.R., KHERA, G.S. & BLEICHMAR, J. (2001). Treatment histories of borderline inpatients. Comprehensive Psychiatry, 42(2), 144-150.
  • ZISOOK, S., GOFF, A., SLEDGE, P. & SHUCHTER, S.R. (1994). Reported suicidal behavior and current suicidal ideation in a psychiatric outpatient clinic. Annals of Clinical Psychiatry, 6(1), 27-31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.